Teva Picks Lundbeck’s Schultz to Revive Israeli Drugmaker – Bloomberg
Bloomberg |
Teva Picks Lundbeck's Schultz to Revive Israeli Drugmaker
Bloomberg Teva Pharmaceutical Industries Ltd. named H. Lundbeck A/S's Kaare Schultz as its new chief executive officer, ending a seven-month search for a new leader to revive sales and reduce debt at the world's largest maker of generic drugs. Schultz, 56, will … Changes in Executive Management in LundbeckGlobeNewswire (press release) |